1. You Are At:
  2. English News
  3. Business News
  4. Sensex, Nifty resume record run on F&O expiry

Sensex, Nifty resume record run on F&O expiry

Sensex resumed its record-setting spree. NSE Nifty also settled at a new closing peak on Thursday.

Mumbai Updated on: May 30, 2019 17:19 IST
Share Markets closing
Image Source : PTI (FILE)

Share market

After a day's breather, benchmark Sensex Thursday resumed its record-setting spree by rallying 330 points on gains in index heavyweights RIL, HDFC and TCS amid expiry of May derivative contracts.

Moreover, sentiment was driven by renewed hopes from the new government as investors have been keenly awaiting the allocation of key portfolios to ministers. Narendra Modi and his council of ministers are all set to take oath at 1900 hours Wednesday.

After soaring over 400 points, the 30-share index ended 329.92 points, or 0.84 per cent, higher at 39,831.97 -- its fresh-closing high. The gauge hit an intra-day high of 39,911.92 and a low of 39,500.56.

The broader NSE Nifty also settled at a new closing peak at 11,945.90, gaining 84.80 points or 0.71 per cent.

NTPC was the top gainer in the Sensex pack, rallying 3.44 per cent. Bharti Airtel, Bajaj Finance, TCS, HDFC twins, Yes Bank and RIL too gained up to 2.33 per cent.

While, Sun Pharma, M&M, ONGC, IndusInd Bank and Vedanta fell up to 2.39 per cent.

Foreign institutional investors (FIIs) sold equities worth Rs 304.27 crore on Wednesday and domestic institutional investors (DIIs) offloaded shares to the tune of Rs 189.58 crore, provisional data available with stock exchanges showed.

Asian bourses ended on a mixed note, while Europe was trading in the green in opening deals.

Meanwhile, the Indian rupee was trading 5 paise lower at 69.88 against the US dollar.

Brent crude, the global benchmark, slipped 0.06 per cent to 67.83 per barrel.

Also Read | Sensex, Nifty start on positive note ahead of F&O expiry

Watch | Arun Jaitley opts out of new Cabinet, cites health challenges

Latest Business News

Fight against Coronavirus: Full coverage

Write a comment